Hepion Pharmaceuticals Stock Alpha and Beta Analysis
| HEPA Stock | USD 0.64 0.03 4.48% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Hepion Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Hepion Pharmaceuticals over a specified time horizon. Remember, high Hepion Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Hepion Pharmaceuticals' market risk premium analysis include:
Beta 1.56 | Alpha (0.37) | Risk 5.53 | Sharpe Ratio (0.05) | Expected Return (0.28) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Hepion |
Hepion Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Hepion Pharmaceuticals market risk premium is the additional return an investor will receive from holding Hepion Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hepion Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Hepion Pharmaceuticals' performance over market.| α | -0.37 | β | 1.56 |
Hepion Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Hepion Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Hepion Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Hepion Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Hepion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hepion Pharmaceuticals shares will generate the highest return on investment. By understating and applying Hepion Pharmaceuticals stock market price indicators, traders can identify Hepion Pharmaceuticals position entry and exit signals to maximize returns.
Hepion Pharmaceuticals Return and Market Media
The median price of Hepion Pharmaceuticals for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 0.68 with a coefficient of variation of 8.51. The daily time series for the period is distributed with a sample standard deviation of 0.06, arithmetic mean of 0.68, and mean deviation of 0.04. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Hepion Pharmaceuticals faces Nasdaq delisting over share price - Investing.com | 09/05/2024 |
2 | Acquisition by Lbiati Kaouthar of 85000 shares of Hepion Pharmaceuticals at 2.56 subject to Rule 16b-3 | 09/10/2024 |
3 | Phathom Pharmaceuticals Shares Down 4 percent - MarketBeat | 09/23/2024 |
4 | Hepion Pharma Two B Merger Advances SEC Approves Key Registration for HEPA Deal HEPA Stock News - StockTitan | 11/11/2024 |
5 | Acquisition by Foster Robert T of 44082 shares of Hepion Pharmaceuticals subject to Rule 16b-3 | 11/15/2024 |
6 | Hepion Pharmaceuticals faces Nasdaq delisting risk | 11/22/2024 |
About Hepion Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Hepion or other stocks. Alpha measures the amount that position in Hepion Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Net Debt To EBITDA | 3.0 | 1.17 | 0.3 | 0.28 | Intangibles To Total Assets | 0.0489 | 0.053 | 0.0609 | 0.0578 |
Hepion Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Hepion Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Hepion Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Hepion Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Hepion Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Hepion Pharmaceuticals' management manipulating its earnings.
| 19th of February 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 19th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Hepion Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Hepion Pharmaceuticals Backtesting, Hepion Pharmaceuticals Valuation, Hepion Pharmaceuticals Correlation, Hepion Pharmaceuticals Hype Analysis, Hepion Pharmaceuticals Volatility, Hepion Pharmaceuticals History and analyze Hepion Pharmaceuticals Performance. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Hepion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.